TargetMol

Amethopterin

Product Code:
 
TAR-T29965
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29965-50mg50mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29965-100mg100mg£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Amethopterin is a chemotherapy drug and immune system inhibitor used to treat cancers of the blood, bone, lung, breast, head, and neck. In addition, it can treat rheumatoid arthritis and psoriasis.
CAS:
60388-53-6
Formula:
C20H22N8O5
Molecular Weight:
454.447
Purity:
0.98
SMILES:
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)NC(CCC(O)=O)C(O)=O

References

1. Suzuki R. NK/T Cell Lymphoma: Updates in Therapy. Curr Hematol Malig Rep. 2018 Jan 24. doi: 10.1007/s11899-018-0430-5. [Epub ahead of print] Review. PubMed PMID: 29368155. 2. McDaniel BL, Bentley ML. The role of medications and their management in acute kidney injury. Integr Pharm Res Pract. 2015 May 18;4:21-29. doi: 10.2147/IPRP.S52930. eCollection 2015. Review. PubMed PMID: 29354517; PubMed Central PMCID: PMC5741024. 3. Ustekinumab (Stelara) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK476185/ PubMed PMID: 29356468. 4. Prad?re B, Thibault C, Vetterlein MW, Leow JJ, Peyronnet B, Roupr?t M, Seisen T. Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017. Transl Androl Urol. 2017 Dec;6(6):1049-1059. doi: 10.21037/tau.2017.09.12. Review. PubMed PMID: 29354492; PubMed Central PMCID: PMC5760386.